0 Evaluaciones
ID

41484

Descripción

Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT02248428

Link

https://clinicaltrials.gov/show/NCT02248428

Palabras clave

Versiones (1)
  1. 26/10/20 26/10/20 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

26 de octubre de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility Multiple Myeloma NCT02248428

    Inglés

    Eligibility Multiple Myeloma NCT02248428

    1 formularios  
    Inclusion Criteria
    Descripción

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    signed informed consent form
    Descripción

    Signed informed consent form

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    adhere to the study visit schedule and other protocol requirements
    Descripción

    Ability to meet study requirements

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0525058
    diagnosed with active multiple myeloma
    Descripción

    active multiple myeloma

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0205177
    UMLS CUI [1,2]
    C0026764
    myeloma previously untreated
    Descripción

    previously untreated

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0332155
    UMLS CUI [1,2]
    C0026764
    karnofsky performance status(kps) ≥50
    Descripción

    karnofsky performance status

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    karnofsky performance status (kps) <50 related to bony disease
    Descripción

    karnofsky performance status

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0206065
    UMLS CUI [1,2]
    C0439849
    UMLS CUI [1,3]
    C0005940
    new york heart association (nyha) functional ≤ class iii
    Descripción

    new york heart association

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1275491
    Exclusion Criteria
    Descripción

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics;
    Descripción

    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0055856
    UMLS CUI [2,1]
    C0020517
    UMLS CUI [2,2]
    C0055856
    UMLS CUI [2,3]
    C0015237
    UMLS CUI [3,1]
    C0020517
    UMLS CUI [3,2]
    C0014806
    UMLS CUI [4,1]
    C0020517
    UMLS CUI [4,2]
    C0003240
    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin;
    Descripción

    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0072916
    UMLS CUI [2,1]
    C2347852
    UMLS CUI [2,2]
    C0031935
    UMLS CUI [3,1]
    C2347852
    UMLS CUI [3,2]
    C0085170
    UMLS CUI [4,1]
    C2347852
    UMLS CUI [4,2]
    C0085173
    UMLS CUI [5,1]
    C2347852
    UMLS CUI [5,2]
    C0014710
    UMLS CUI [6,1]
    C2347852
    UMLS CUI [6,2]
    C0012291
    UMLS CUI [7,1]
    C2347852
    UMLS CUI [7,2]
    C0074554
    UMLS CUI [8,1]
    C2347852
    UMLS CUI [8,2]
    C0024027
    UMLS CUI [9,1]
    C2347852
    UMLS CUI [9,2]
    C0286651
    a history of cholestatic jaundice/hepatic dysfunction associated with prior use of clarithromycin
    Descripción

    previous cholestatic jaundice/hepatic dysfunction linked to use of clarithromycin

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0205156
    UMLS CUI [1,2]
    C0008370
    UMLS CUI [1,3]
    C0022346
    UMLS CUI [1,4]
    C0332281
    UMLS CUI [1,5]
    C0055856
    UMLS CUI [2,1]
    C0205156
    UMLS CUI [2,2]
    C0086565
    UMLS CUI [2,3]
    C0332281
    UMLS CUI [2,4]
    C0055856
    impaired renal function,creatinine ≥221umol/l；
    Descripción

    abnormal renal function, creatinine

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0201976
    UMLS CUI [2]
    C0151746
    pregnant or breast feeding females
    Descripción

    pregnant or breast feeding

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    any condition which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study.
    Descripción

    condition placing the subject at unacceptable risk in case of study participation or confounds the study's data interpretation

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0012634
    UMLS CUI [1,2]
    C2348568
    UMLS CUI [1,3]
    C1883420
    UMLS CUI [1,4]
    C0035647
    UMLS CUI [2,1]
    C0012634
    UMLS CUI [2,2]
    C0392760
    UMLS CUI [2,3]
    C0681873
    UMLS CUI [2,4]
    C0459471
    Volver a la parte superior de la página

    Similar models

    Eligibility Multiple Myeloma NCT02248428

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Signed informed consent form
    Item
    signed informed consent form
    boolean
    C0021430 (UMLS CUI [1])
    Ability to meet study requirements
    Item
    adhere to the study visit schedule and other protocol requirements
    boolean
    C0525058 (UMLS CUI [1])
    active multiple myeloma
    Item
    diagnosed with active multiple myeloma
    boolean
    C0205177 (UMLS CUI [1,1])
    C0026764 (UMLS CUI [1,2])
    previously untreated
    Item
    myeloma previously untreated
    boolean
    C0332155 (UMLS CUI [1,1])
    C0026764 (UMLS CUI [1,2])
    karnofsky performance status
    Item
    karnofsky performance status(kps) ≥50
    boolean
    C0206065 (UMLS CUI [1])
    karnofsky performance status
    Item
    karnofsky performance status (kps) <50 related to bony disease
    boolean
    C0206065 (UMLS CUI [1,1])
    C0439849 (UMLS CUI [1,2])
    C0005940 (UMLS CUI [1,3])
    new york heart association
    Item
    new york heart association (nyha) functional ≤ class iii
    boolean
    C1275491 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics
    Item
    hypersensitivity to clarithromycin or any of its excipients, erythromycin, or any of the macrolide antibiotics;
    boolean
    C0020517 (UMLS CUI [1,1])
    C0055856 (UMLS CUI [1,2])
    C0020517 (UMLS CUI [2,1])
    C0055856 (UMLS CUI [2,2])
    C0015237 (UMLS CUI [2,3])
    C0020517 (UMLS CUI [3,1])
    C0014806 (UMLS CUI [3,2])
    C0020517 (UMLS CUI [4,1])
    C0003240 (UMLS CUI [4,2])
    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin
    Item
    concomitant administration of cisapride, pimozide, astemizole, terfenadine, ergotamine or dihydroergotamine, simvastatin, lovastatin, and atorvastatin;
    boolean
    C2347852 (UMLS CUI [1,1])
    C0072916 (UMLS CUI [1,2])
    C2347852 (UMLS CUI [2,1])
    C0031935 (UMLS CUI [2,2])
    C2347852 (UMLS CUI [3,1])
    C0085170 (UMLS CUI [3,2])
    C2347852 (UMLS CUI [4,1])
    C0085173 (UMLS CUI [4,2])
    C2347852 (UMLS CUI [5,1])
    C0014710 (UMLS CUI [5,2])
    C2347852 (UMLS CUI [6,1])
    C0012291 (UMLS CUI [6,2])
    C2347852 (UMLS CUI [7,1])
    C0074554 (UMLS CUI [7,2])
    C2347852 (UMLS CUI [8,1])
    C0024027 (UMLS CUI [8,2])
    C2347852 (UMLS CUI [9,1])
    C0286651 (UMLS CUI [9,2])
    previous cholestatic jaundice/hepatic dysfunction linked to use of clarithromycin
    Item
    a history of cholestatic jaundice/hepatic dysfunction associated with prior use of clarithromycin
    boolean
    C0205156 (UMLS CUI [1,1])
    C0008370 (UMLS CUI [1,2])
    C0022346 (UMLS CUI [1,3])
    C0332281 (UMLS CUI [1,4])
    C0055856 (UMLS CUI [1,5])
    C0205156 (UMLS CUI [2,1])
    C0086565 (UMLS CUI [2,2])
    C0332281 (UMLS CUI [2,3])
    C0055856 (UMLS CUI [2,4])
    abnormal renal function, creatinine
    Item
    impaired renal function,creatinine ≥221umol/l；
    boolean
    C0201976 (UMLS CUI [1])
    C0151746 (UMLS CUI [2])
    pregnant or breast feeding
    Item
    pregnant or breast feeding females
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    condition placing the subject at unacceptable risk in case of study participation or confounds the study's data interpretation
    Item
    any condition which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study.
    boolean
    C0012634 (UMLS CUI [1,1])
    C2348568 (UMLS CUI [1,2])
    C1883420 (UMLS CUI [1,3])
    C0035647 (UMLS CUI [1,4])
    C0012634 (UMLS CUI [2,1])
    C0392760 (UMLS CUI [2,2])
    C0681873 (UMLS CUI [2,3])
    C0459471 (UMLS CUI [2,4])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial